← Evidence map

ArticleOncotarget2017

miR-503-5p confers drug resistance by targeting PUMA in colorectal carcinoma.

Ke Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

33 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 28423513